PACT for Metastatic Lung Carcinoma
This study is evaluating whether a mobile application may help people prepare for end of life care.
See full descriptionAbout the trial for Metastatic Lung Carcinoma
Treatment Groups
This trial involves 3 different treatments. PACT is the primary treatment being studied. Participants will be divided into 2 treatment groups. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
About The Treatment
Eligibility
This trial is for patients born any sex aged 18 and older. There are 10 eligibility criteria to participate in this trial as listed below.
Approximate Timelines
Measurement Requirements
This trial is evaluating whether PACT will improve 6 primary outcomes and 5 secondary outcomes in patients with Metastatic Lung Carcinoma. Measurement will happen over the course of Baseline, 3 months post-intervention, and 6 months post-intervention.
Patient Q & A Section
What causes to evaluate pact, a mobile application for improving engagement in advance care planning?
There are multiple factors at play in relation to the evaluation of a mobile technology product such as pact. These include design features, user factors, and technology characteristics. These factors are intertwined in a complex way. In this paper, multiple levels of design features and user factors that affect the impact pact had on users and the technology characteristics of pact that influence whether one would use the app to support advance care planning was explored.
What is to evaluate pact, a mobile application for improving engagement in advance care planning?
A web-based patient engagement program significantly increases participation of patients in AODP compared to wait-list control. The program can be further developed for use by healthcare providers to improve patients' engagement in AODP and improve patient outcomes in health care.
What are the signs of to evaluate pact, a mobile application for improving engagement in advance care planning?
Inclusion of EHR features into pact may increase engagement in advance care planning. However, future research is needed to assess the impact of this feature of pact on patient engagement.
What are common treatments for to evaluate pact, a mobile application for improving engagement in advance care planning?
To evaluate pact, we provide a novel platform to assess patient engagement. This approach may help to advance the field of mobile health and telehealth by allowing health consumers to engage in clinical care or personal health care by exchanging information and engaging in other digital activities in the clinic context.
How many people get to evaluate pact, a mobile application for improving engagement in advance care planning a year in the United States?
Nearly 12% of people in the United States who are eligible for EMR do not get to evaluate their pact after their provider makes a recommendation to them.
Can to evaluate pact, a mobile application for improving engagement in advance care planning be cured?
In a recent study, findings did not find a cost-effective mobile application that can be used to encourage patients to engage in advance care planning or to assess their advance care plan.
Who should consider clinical trials for to evaluate pact, a mobile application for improving engagement in advance care planning?
A large part of the US general primary care population could be contacted to participate in a clinical trial for a new device to aid with planning care. Physicians had relatively good recommendations of patients to participate in clinical trials but less positive comments about a new device.
Have there been other clinical trials involving pact?
There has been one trial-based study of pact for patients with advanced dementia, which was based on a small sample. There is a need for further studies about pact and other methods of improving engagement for patients wishing to consider end-of-life care.
Does pact improve quality of life for those with to evaluate pact, a mobile application for improving engagement in advance care planning?
pact may be more effective for communicating and informing about advance care planning options and more effective than discussing personal preferences for end-of-life care, supporting the hypothesis that the use of pact could improve end-of-life care discussion with individuals with advance care planning.
How serious can to evaluate pact, a mobile application for improving engagement in advance care planning be?
The Pact system is a valid and reliable service which can be used to collect and analyse medical-practice related patient data. PACT was the primary contributor to the engagement process, but we argue that further improvements in the system might be attained, mainly through improvements in its support portal.
What is the average age someone gets to evaluate pact, a mobile application for improving engagement in advance care planning?
Most people in both age groups evaluated pact, but people who are over 75 had a stronger engagement in advance care planning, suggesting that they could be more confident in their decision making ability after the evaluation of Pact.
What are the latest developments in pact for therapeutic use?
Mobile pact can help advance advance care planning by engaging and encouraging patients to communicate their views at intervals after receiving the app. For each question answered, people accumulating more points is associated with more engagement, which is then linked to better patient satisfaction. This will help physicians create an interactive platform for patients and their families to discuss plan choices and treatment decisions with patients when appropriate.